Checkmate Logo Horizontal White.png
  • About Us

  • Our Team

  • Portfolio

  • Our Thesis

  • Advisory

  • News & Press

  • Contact

  • More

    Use tab to navigate through the menu items.
    NeuroSigma Announces MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD
    • Apr 7

    NeuroSigma Announces MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD

    NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to...
    The RepTrak Company Announces Acquisition of Checkmate Capital Advised ESG Analytics
    • Mar 9

    The RepTrak Company Announces Acquisition of Checkmate Capital Advised ESG Analytics

    March 7, 2022 - Boston, MA - The RepTrak Company, the world’s leading reputation data and insights company, today announced the...
    NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
    • Feb 22

    NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®

    LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA...
    Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in China
    • Jan 26

    Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in China

    Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in China Initial launch of Generation 1.0...
    NeuroSigma Announces Promotion of Dr. Colin Kealey to President
    • Jan 11

    NeuroSigma Announces Promotion of Dr. Colin Kealey to President

    LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) - NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion...
    NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
    • Dec 8, 2021

    NeuroSigma Announces a $5 Million Equity Investment by KT Corporation

    Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KT Significant investment...
    Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
    • Nov 3, 2021

    Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group

    SAN DIEGO, CA, November 3, 2021 (GLOBE NEWSWIRE) – Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today...
    Earth Holdings Acquires Austin Landscape Supplies
    • Sep 14, 2021

    Earth Holdings Acquires Austin Landscape Supplies

    Acquisition to be Integrated with Organics by Gosh to Provide a Leading Presence in the Greater Austin Area for Organic Soil Products and...

    © 2022 Checkmate Capital Group LLC